ClinicalTrials.Veeva

Menu

Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation (EVLP XPS)

H

Hannover Medical School (MHH)

Status

Enrolling

Conditions

Lung Transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT06795516
EVLP XPS 2023

Details and patient eligibility

About

Clinical use of ex-vivo perfusion for lung transplantation. Collection, storage and processing of patient data for outcome analysis.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Min Age 18 years
  • Acceptance of the organ using the XPS™ ex vivo lung perfusion system is made by the center based on clinical assessment and visual inspection

Exclusion criteria

  • The usual criteria for the assessment of donors apply
  • The transplanting surgeon is not satisfied with the lung assessment on the XPS™ according to clinical criteria

Trial contacts and locations

1

Loading...

Central trial contact

Fabio Ius, Prof. Dr.; Susanne Freyt

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems